Compound 2181
Identifiers
- Canonical SMILES:
COc1c(C)cc(cc1C)N=Nc1ccc(cc1)S(=O)(=O)Nc1ccccn1
- IUPAC name:
4-[2-(4-methoxy-3,5-dimethylphenyl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide
- InChi:
InChI=1S/C20H20N4O3S/c1-14-12-17(13-15(2)20(14)27-3)23-22-16-7-9-18(10-8-16)28(25,26)24-19-6-4-5-11-21-19/h4-13H,1-3H3,(H,21,24)
- InChiKey:
XSXTVZGIXAQCCK-UHFFFAOYSA-N
External links
![]() 72735611 |
External search
|
|
|
|
|
Bibliography (1)
Pharmacological data
| Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|
| 0 | 0 | 0 | 0 |
Targets
| PPI family | Best activity | Diseases | MMoA |
|---|
Physicochemical filters
| Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
|---|---|---|---|---|
| Compliance | ||||
| MW | 396.13 g/mol | |||
| HBA | 7 | |||
| HBD | 1 | |||
| HBA + HBD | 8 | |||
| AlogP | 5.11 | |||
| TPSA | 90.21 | |||
| RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
| Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 |
Pharmacological data
| Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
|---|
| Ta | Structure | Name | Drugbank ID |
|---|---|---|---|
| 0.8062 | Sulfasalazine | DB00795 | |
| 0.6518 | Sulfapyridine | DB00891 | |
| 0.5208 | N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE | DB07944 | |
| 0.5105 | Sulfamethoxypyridazine | DB13773 | |
| 0.5102 | Sulfaethoxypyridazine | DB11462 | |
| 0.5034 | ABT-751 | DB12254 | |
| 0.5000 | Sulfameter | DB06821 | |
| 0.4962 | Sulfaquinoxaline | DB11464 | |
| 0.4959 | Sulfaperin | DB13320 | |
| 0.4833 | Sulfadiazine | DB00359 | |
| 0.4809 | Sulfamethazine | DB01582 | |
| 0.4685 | Sulfachlorpyridazine | DB11461 | |
| 0.4656 | Sulfamerazine | DB01581 | |
| 0.4623 | Elismetrep | DB15287 | |
| 0.4610 | AMG-131 | DB05490 |




